VR-ACT After Stroke: a Feasibility Study
Not yet recruitingNot applicableNCT06990646
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).
Study details
- Official title
- VR-ACT After Stroke: a Feasibility RCT of a Virtual Reality Delivery of ACT for Pain Management and Mental Health in Patients With Chronic Post-Stroke Pain
- Conditions
- Interventions
- Behavioral: VR-ACT
- Behavioral: Sham-VR
- Sponsor
- University of Coimbra
- Collaborators
- Unidade Local de Saúde de Coimbra, EPE
- Start date
- 2025-11
- Primary completion
- 2026-03
- Sex
- All
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Total sites listed
- 0
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * medical diagnosis of CPSP; * age between 18 and 80; * implicit de facto internet and computer literacy; * willingness to comply with the study procedures. Exclusion Criteria: * currently with active malignancy; - * severe cognitive impairment; * currently undergoing any psychological intervention or VR-delivered pain management program; * current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month); * language impairment with severe comprehension deficit; * history of photosensitive epilepsy or previous experience of severe simulator sickness; * other neurological conditions (e.g., dementia; Parkinson´s).
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06990646